Clinical Trial Update: Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)

View source ↗

Summary

This clinical trial update reports a retrospective assessment of response to Faslodex (fulvestrant) 500 mg. The study involves patients with metastatic breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: Isabel Blancas | Conditions: Malignant Neoplasm of Breast Stage IV | Status: COMPLETED | Results posted: 2016-06-01